UNKNOWN_NEUROVASCULAR_PRODUCT UNK_NEU

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2016-04-08 for UNKNOWN_NEUROVASCULAR_PRODUCT UNK_NEU manufactured by Boston Scientific - Minn.

Event Text Entries

[42235942] The exact date of the adverse event is unknown. All patients were treated between (b)(6) 2013 and (b)(6) 2015. This report is 2 of 2 covering balloon treated patients that experienced strokes, transient ischemic attacks and death. The subject device is not available.
Patient Sequence No: 1, Text Type: N, H10


[42235943] The stroke journal documented the results of a thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis. The article informed that 141 patients were treated with the balloon (subject device) pre-dilation plus self-expanding stenting. Of the patients treated, 6 patients had a 30 days primary end points of stroke, transient ischemic attack, and death. In addition, 6 patients had secondary end points of unsuccessful revascularization. It was not possible to ascertain specific device or patient information from the article, or to match the events reported with previously reported complaints. No additional information is available.
Patient Sequence No: 1, Text Type: D, B5


[47896765] A review of the device history record could not be performed because the lot number was not reported. The subject device is not available; therefore, functional testing as well as physical analysis cannot be performed. However, transient ischemic attack(tia), stroke and death are known risks associated with endovascular procedures and are listed as such in the device directions for use (dfu). Therefore, an assignable cause of anticipated procedural complications was assigned to this event.
Patient Sequence No: 1, Text Type: N, H10


[47896766] The stroke journal documented the results of a thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis. The article informed that 141 patients were treated with the balloon (subject device) pre-dilation plus self-expanding stenting. Of the patients treated, 6 patients had a 30 days primary end points of stroke, transient ischemic attack, and death. In addition, 6 patients had secondary end points of unsuccessful revascularization. It was not possible to ascertain specific device or patient information from the article, or to match the events reported with previously reported complaints. No additional information is available.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3008853977-2016-00128
MDR Report Key5564667
Report SourceHEALTH PROFESSIONAL
Date Received2016-04-08
Date of Report2016-03-11
Date of Event2013-09-01
Date Mfgr Received2016-05-25
Date Added to Maude2016-04-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. SANDA DRACIC
Manufacturer Street47900 BAYSIDE PARKWAY
Manufacturer CityFREMONT CA 94538
Manufacturer CountryUS
Manufacturer Postal94538
Manufacturer Phone5104132500
Manufacturer G1BOSTON SCIENTIFIC - MINN
Manufacturer StreetONE SCIMED PLACE
Manufacturer CityMAPLE GROVE MN 55311
Manufacturer CountryUS
Manufacturer Postal Code55311
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameUNKNOWN_NEUROVASCULAR_PRODUCT
Generic NameCATHETER, BALLOON TYPE
Product CodePAV
Date Received2016-04-08
Catalog NumberUNK_NEU
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No0
Device Event Key0
ManufacturerBOSTON SCIENTIFIC - MINN
Manufacturer AddressONE SCIMED PLACE MAPLE GROVE MN 55311 US 55311


Patients

Patient NumberTreatmentOutcomeDate
101. Death; 2. Other 2016-04-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.